{"disease":{"id":"nmo-spectrum-disorder","name":"nmo spectrum disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05154370","title":"China National Registry of Neuro-Inflammatory Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT06443333","title":"National, Multicentric Registry Study on Neuroimmunological Diseases in China","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05414890","title":"Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04355611","title":"Epidemiological Characteristics of COVID-19 in Patients With MS or NMO","phase":"","overall_status":"COMPLETED","enrollment_count":2465,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07333196","title":"Tongji NADs Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1550,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04106830","title":"Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT04822623","title":"Imaging Evaluation of Central Nervous Autoimmune Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT05004493","title":"Biorepository and Registry for Plasma Exchange Patients","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Charles M Knudson","has_results":false},{"nct_id":"NCT06885957","title":"Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07132398","title":"Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":170,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT05403138","title":"Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":135,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT03766347","title":"Pediatric NMOSD Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07304960","title":"Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT02073279","title":"Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT02028884","title":"Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT05432713","title":"A Study of LP-168 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Guangzhou Lupeng Pharmaceutical Company LTD.","has_results":false},{"nct_id":"NCT05896605","title":"Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"First Affiliated Hospital of Guangxi Medical University","has_results":false},{"nct_id":"NCT06497374","title":"FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":63,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT05145361","title":"Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Shanghai Pharmaceuticals Holding Co., Ltd","has_results":false},{"nct_id":"NCT05840055","title":"ACT with NMOSD Patients and Caregivers Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT07022197","title":"Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT06724809","title":"Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":21,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05154734","title":"Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT05792462","title":"Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT07377305","title":"Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)","phase":"NA","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT04227470","title":"A Study of HBM9161 in NMOSD Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Harbour BioMed (Guangzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT06548620","title":"A Study of RD06-04 in Patients With Active Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Nanjing Bioheng Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT05974293","title":"A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Michael, Levy M.D.,Ph.D.","has_results":false}],"total":28},"guidelines":[],"source":"Drug Landscape verified database"}